ELV vs NDAQ · P/E 18, rev $199.13B vs P/E 41, rev $2.53B
Elevance Health Inc (ELV) versus Nasdaq Inc (NDAQ) — a side-by-side from cached financials, not a winner call.
Elevance Health Inc (ELV) is a healthcare plans company listed on US.
Nasdaq Inc (NDAQ) is a financial data & stock exchanges company listed on US.
Latest reported ELV revenue for 2025-12-31 was $199.13B. Net income was $5.66B. Revenue was up 12.5% from 2024-12-31 to 2025-12-31. ELV currently screens at market cap $90.24B and trailing P/E 17.6.
Latest reported NDAQ revenue for 2026-06-30 was $2.53B. Net income was $507.0M. Revenue was up 18.5% from 2026-03-31 to 2026-06-30. NDAQ currently screens at market cap $51.71B and trailing P/E 40.8.
ELV currently screens at market cap $90.24B and trailing P/E 17.6. NDAQ currently screens at market cap $51.71B and trailing P/E 40.8.
Not investment advice. Open the ELV and NDAQ stock pages for the full models.
Not investment advice.